tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

PRF Technologies Files First Patent for AI-Driven Solar Micro-Climate Forecasting

Story Highlights
  • PRF Technologies filed a patent on January 20, 2026 for micro-climate modeling methods to improve solar plant production forecasting accuracy.
  • The patent strengthens PRF’s DeepSolar Predict platform and IP portfolio, aiming to boost revenue optimization and risk management for utility-scale solar operators in competitive power markets.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
PRF Technologies Files First Patent for AI-Driven Solar Micro-Climate Forecasting

Claim 50% Off TipRanks Premium

PainReform ( (PRFX) ) just unveiled an update.

On January 20, 2026, PRF Technologies announced it had filed its first patent application for proprietary micro-climate modeling methods designed to significantly enhance the accuracy of power production forecasts at individual solar plants. The filing, which follows the company’s acceptance into the NVIDIA Connect Program, underpins its DeepSolar Predict forecasting platform and targets a key weakness in conventional, region-based solar forecasts by continuously adapting to localized weather conditions at each installation. By improving short-term and intraday forecast precision, PRF aims to help utility-scale solar operators and energy traders better manage revenue, reduce penalties tied to forecast errors, and optimize participation in volatile electricity markets. The move strengthens PRF’s growing portfolio of energy-focused intellectual property and supports its broader strategy to expand in data-driven renewable energy optimization, potentially reinforcing its position at the intersection of AI, clean energy, and financial performance for solar assets.

The most recent analyst rating on (PRFX) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on PainReform stock, see the PRFX Stock Forecast page.

Spark’s Take on PRFX Stock

According to Spark, TipRanks’ AI Analyst, PRFX is a Neutral.

The score is held down primarily by weak financial performance (negligible revenue, widening losses, and worsening cash burn with declining equity). Technicals provide partial support in the near term (trading above key short-term averages), but the longer-term trend remains weak (below the 200-day), and valuation cannot be meaningfully assessed due to missing P/E and dividend yield.

To see Spark’s full report on PRFX stock, click here.

More about PainReform

PRF Technologies Ltd. (formerly PainReform) is a dual-focused company active in both pharmaceuticals and energy optimization technologies. On the healthcare side, it develops reformulations of established therapeutics using a proprietary extended-release drug-delivery system aimed at providing prolonged post-surgical pain relief while reducing repeat dosing and opioid dependence. In parallel, through its DeepSolar platform, the company offers AI-driven software that helps consumers and enterprises monitor, forecast, and optimize energy consumption, with a particular emphasis on utility-scale and solar-integrated environments, reflecting a strategy that spans high-impact sectors from healthcare to sustainable energy.

Average Trading Volume: 1,747,354

Technical Sentiment Signal: Sell

Current Market Cap: $4.42M

Find detailed analytics on PRFX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1